These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 23966157

  • 1. The role of EMMPRIN expression in ovarian epithelial carcinomas.
    Zhao Y, Chen S, Gou WF, Niu ZF, Zhao S, Xiao LJ, Takano Y, Zheng HC.
    Cell Cycle; 2013 Sep 01; 12(17):2899-913. PubMed ID: 23966157
    [Abstract] [Full Text] [Related]

  • 2. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y, Zheng HC, Chen S, Gou WF, Xiao LJ, Niu ZF.
    Gynecol Oncol; 2013 Sep 01; 130(3):570-8. PubMed ID: 23764197
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.
    Zheng HC, Wang W, Xu XY, Xia P, Yu M, Sugiyama T, Takano Y.
    J Cancer Res Clin Oncol; 2011 Apr 01; 137(4):585-96. PubMed ID: 20514493
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer.
    Zhao SH, Wang Y, Wen L, Zhai ZB, Ai ZH, Yao NL, Wang L, Liu WC, Chen BL, Li Y, Yang H.
    J Transl Med; 2013 Apr 08; 11():92. PubMed ID: 23566400
    [Abstract] [Full Text] [Related]

  • 10. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.
    Zhao Y, Chen S, Gou WF, Xiao LJ, Takano Y, Zheng HC.
    Tumour Biol; 2014 Mar 08; 35(3):1955-64. PubMed ID: 24132590
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F, Tian J, Cui M, Fang M, Yang L.
    Mol Med Rep; 2015 Jul 08; 12(1):753-9. PubMed ID: 25738807
    [Abstract] [Full Text] [Related]

  • 17. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
    Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R.
    Clin Exp Metastasis; 2003 Jul 08; 20(2):161-9. PubMed ID: 12705637
    [Abstract] [Full Text] [Related]

  • 18. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
    Chen S, Zhao Y, Gou WF, Zhao S, Takano Y, Zheng HC.
    PLoS One; 2013 Jul 08; 8(11):e79781. PubMed ID: 24236158
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
    Chen S, Chen X, Xiu YL, Sun KX, Zhao Y.
    Cancer Lett; 2015 Jun 28; 362(1):122-30. PubMed ID: 25819031
    [Abstract] [Full Text] [Related]

  • 20. [MicroRNA-16 regulates the proliferation, invasion and apoptosis of ovarian epithelial carcinoma cells in vitro].
    Tang R, Cui ZM, Lou YH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov 28; 47(11):846-50. PubMed ID: 23302126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.